Lyell Immunopharma shares owned by China Universal Asset Management
Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by China Universal Asset Management
from 13F filings
Historical chart of China Universal Asset Management investment in Lyell Immunopharma
Tip: Access up to 7 years of quarterly data
All positions including Lyell Immunopharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lyell Immunopharma by China Universal Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $38k | 59k | 0.64 |
| 2024-09-30 | $68k | 49k | 1.38 |
| 2024-06-30 | $43k | 30k | 1.45 |
| 2024-03-31 | $109k | 49k | 2.23 |
| 2023-12-31 | $57k | 29k | 1.94 |
| 2023-09-30 | $9.5k | 6.4k | 1.47 |
| 2023-06-30 | $10k | 3.3k | 3.18 |
| 2023-03-31 | $8.0k | 3.4k | 2.36 |
| 2022-12-31 | $8.8k | 2.5k | 3.47 |
| 2022-09-30 | $17k | 2.3k | 7.32 |
More positions owned by China Universal Asset Management
View all positions for China Universal Asset Management